Allurion Technologies Inc. (ALUR)

USD 2.78

(-4.14%)

Total Assets Summary of Allurion Technologies Inc.

  • Allurion Technologies Inc.'s latest annual total assets in 2023 was 71.71 Million USD , up 39.6% from previous year.
  • Allurion Technologies Inc.'s latest quarterly total assets in 2024 Q2 was 46.55 Million USD , down -22.4% from previous quarter.
  • Allurion Technologies Inc. reported annual total assets of 51.37 Million USD in 2022, up 30.54% from previous year.
  • Allurion Technologies Inc. reported annual total assets of 39.35 Million USD in 2021, up 11825.81% from previous year.
  • Allurion Technologies Inc. reported quarterly total assets of 46.55 Million USD for 2024 Q2, down -22.4% from previous quarter.
  • Allurion Technologies Inc. reported quarterly total assets of 120.68 Million USD for 2023 Q3, up 131.42% from previous quarter.

Annual Total Assets Chart of Allurion Technologies Inc. (2023 - 2020)

Historical Annual Total Assets of Allurion Technologies Inc. (2023 - 2020)

Year Total Assets Total Assets Growth
2023 71.71 Million USD 39.6%
2022 51.37 Million USD 30.54%
2021 39.35 Million USD 11825.81%
2020 329.96 Thousand USD 0.0%

Peer Total Assets Comparison of Allurion Technologies Inc.

Name Total Assets Total Assets Difference
Abbott Laboratories 73.21 Billion USD 99.902%
Artivion, Inc. 792.39 Million USD 90.95%
Avanos Medical, Inc. 1.69 Billion USD 95.763%
Butterfly Network, Inc. 304.27 Million USD 76.432%
Butterfly Network, Inc. 304.27 Million USD 76.432%
Bio-Rad Laboratories, Inc. 12.29 Billion USD 99.417%
Boston Scientific Corporation 35.13 Billion USD 99.796%
CONMED Corporation 2.3 Billion USD 96.882%
Edwards Lifesciences Corporation 9.36 Billion USD 99.234%
Paragon 28, Inc. 340.69 Million USD 78.952%
Glaukos Corporation 940.41 Million USD 92.374%
Globus Medical, Inc. 5.08 Billion USD 98.59%
Inspire Medical Systems, Inc. 676.81 Million USD 89.404%
Integer Holdings Corporation 2.94 Billion USD 97.563%
Medtronic plc 89.98 Billion USD 99.92%
Myomo, Inc. 14.58 Million USD -391.799%
Nevro Corp. 635.71 Million USD 88.719%
Owlet, Inc. 44.12 Million USD -62.527%
Penumbra, Inc. 1.55 Billion USD 95.392%
Vicarious Surgical Inc. 119.86 Million USD 40.172%
Smith & Nephew plc 9.98 Billion USD 99.282%
Sonendo, Inc. 78.16 Million USD 8.25%
STERIS plc 11.06 Billion USD 99.352%
Stryker Corporation 39.91 Billion USD 99.82%
Vapotherm, Inc. 77.61 Million USD 7.608%
Zimmer Biomet Holdings, Inc. 21.49 Billion USD 99.666%